Company profile for ProteoNic

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ProteoNic is a biotechnology company offering products and services for improving recombinant protein production levels for a range of eukaryotic production platforms. The company’s proprietary 2G UNic™ technology is used to enhance the translation of messenger RNA (mRNA) resulting in more protein per mRNA. This leads to significantly higher yields and greater manufacturing flexibility, with lower production costs. Proteo...
ProteoNic is a biotechnology company offering products and services for improving recombinant protein production levels for a range of eukaryotic production platforms. The company’s proprietary 2G UNic™ technology is used to enhance the translation of messenger RNA (mRNA) resulting in more protein per mRNA. This leads to significantly higher yields and greater manufacturing flexibility, with lower production costs. ProteoNic’s main markets are the biopharmaceutical protein and industrial enzyme production sectors. The company’s activities focus on industry-relevant fungal, yeast, plant, insect and mammalian expression hosts, etc

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
J.H. Oortweg 19-21 2333 CH Leiden
Telephone
Telephone
+31 (0)71 332 27 27
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-11/proteonic-2g-unic-technology-licensed-by-ginkgo-bioworks-for-barda-supported-consortium-advancing-monoclonal-antibody-manufacturing-for-anti-filoviru

PHARMIWEB
11 Dec 2025

https://www.globenewswire.com/news-release/2025/09/15/3150098/0/en/ProteoNic-Launches-2G-UNic-Transposon-Platform-to-Support-Superior-Cell-Line-Productivity-and-Ease-of-Use.html

GLOBENEWSWIRE
15 Sep 2025

https://www.prnewswire.com/news-releases/proteonic-announces-broadening-of-gigagens-rights-to-2g-unic-technology-301664287.html

PRNEWSWIRE
31 Oct 2022

https://www.prnewswire.com/news-releases/proteonic-announces-licensing-of-its-premium-2g-unic-technology-platform-for-production-of-biologics-to-fyonibio-301580346.html

PRNEWSWIRE
05 Jul 2022

https://www.prnewswire.com/news-releases/proteonic-and-necstgen-establish-partnership-to-improve-viral-vector-manufacturing-efficiency-for-gene-therapies-301532972.html

PRNEWSWIRE
26 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty